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. Antibodies against P-gp were purchased from Cell Signaling Technology (Danvers, MA). Antibodies against ERK1/2, p-ERK1/2, Akt, p-Akt caspase-3, and cleaved caspase-3 were also obtained from Cell Signaling Technology. Bcl-2 and bax were purchased from the Proteintech Group (Wuhan, China).
Cell culture
Human CML cells K562 and the related drug-resistant cell lines K562/ADR were purchased from Nanjing KeyGen Biotech Co., Ltd. (Nanjing, China), and they were cultured in RPMI medium 1640 with 10% fetal bovine serum (Thermo Fischer Scientific). Cells were incubated in 5% CO 2 and 95% humidity at 37°C. Cell passages and cell-resistance maintenance were carried out according to the manufacturer's instructions.
Cytotoxicity assay
Drug-induced cytotoxicity was detected with CCK-8 kits. Cells were seeded into 96-well plates at a density of 5 × 10 3 cells/well. After 24 h, cells were treated with the indicated drugs for 48 h. Then, 10 μL of CCK-8 reagent was added to each well and assayed by a microplate reader (Bio-Rad Laboratories, Hercules, CA) at 450 nm. The IC 50 value was calculated using SPSS 22.0 (IBM Corp., Armonk, NY).
Intracellular accumulation of ADR
The cells were plated in 6-well plates at a density of 10 6 cells/well. After 24 h, cells were treated with the indicated drugs for 48 h. Then, 2 mL of 2 μM ADR was added to each well and incubated at 37°C for 45 min in the dark. After incubation, cells were immediately washed three times with ice-cold phosphatebuffered saline, and the cells were lysed with lysate and transferred to opaque 96-well plates for detection of fluorescent signals (495 nm excitation wavelength, 595 nm emission wavelength) using a multimode microplate reader (TriStar2, Berthold Technologies, Bad Wildbad, Germany).
Western blots
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed with 30-μg protein samples, which were loaded into gels. The final membranes were exposed to electrochemiluminescence and photographed using the ChemiDocTM XRS& Imaging system (Bio-Rad Laboratories). The grayscale of the bands was analyzed using Image Lab 3.0 (Bio-Rad Laboratories). The western blot protocol was carried out as previously described in detail [16] .
Real-time quantitative PCR
Gene expression was determined by real-time quantitative PCR (RT-qPCR) following a previously published method [17] . Cells were treated with the indicated reagents for 48 h. The RNAiso Plus® Reagent Kit (Takara Biotechnology, Dalian, China) was used to extract total RNA, and 1 μg of total RNA was used for cDNA reverse transcription. cDNA templates were amplified and detected using the SYBR® Premix Ex TaqTM Kit (Takara Biotechnology) in the ABIPRISM® 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA). Primers used for RT-qPCR were as follows: MDR1 forward primer 5′-GGAGCCTACTTGGTGGCACATAA-3′; MDR1 reverse primer 5′-TGGCATAGTCAGGAGCAAATGAAC-3′; GAPDH forward primer 5′-ACAACTTTGGTATCGTGGAAGG-3′; and GAPDH Reverse primer 5′-GCCATCACGCCACAGTTTC-3′.
Flow cytometry assay
Flow cytometry was used to detect the intracellular accumulation of RHO-123 (C2007, Beyotime Biotechnology, Shanghai, China), reactive oxygen species (ROS; S0033, Beyotime Biotechnology), Annexin V (BMS500FI, Invitrogen), and SYTOX™ Red (S34859, Invitrogen). The cells were plated in 6-well plates at a density of 10 6 cells/well. After 24 h, the cells were pretreated with the corresponding drugs for 48 h. Then, the cells were treated with different dyes according to the manufacturer's instructions and examined by flow cytometric analysis (FACScalibur, BD Biosciences, Franklin Lakes, NJ). 
ATP content detection
The cells were plated in a 6-well plate at a density of 10 6 cells/well. After 24 h, cells were treated with the various drugs for 48 h. The cells were collected, and 300-500 μL of double distilled water was added.
The cells were then homogenized and crushed in hot water. The resulting cell suspension was boiled in water for 10 min and vortexed for 1 min to extract intracellular ATP. An ATP content detection kit purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China) was used to determine the level of ATP in the cells. Then, according to the instructions for the ATP content detection kit (Nanjing Jiancheng Bioengineering Institute), the intracellular ATP content was determined.
Molecular docking simulation
Molecular modelling was performed using Sybyl-x 2.0 software from Tripos Inc. (St. Louis, MO). The P-gp structure used for docking was obtained from the Protein Data Bank (PDB, http://www.rcsb.org; PDB ID, 4M2T and 6C0V). Verapamil, ADR, NFV, ATP, metformin, paclitaxel, colchicine, imatinib, cisplatin, tariquidar, laniquidar, and zosuquidar structures were obtained from zinc 15 (http://zinc15.org) [18] . The co-crystalized ligand and water molecules were removed from the structure, while H atoms were added and side chains were fixed during protein preparation. The Surflex-Dock (SFXC) docking mode was used, and the procedure was conducted as previously described [19] . Surflex-Dock was employed for the molecular docking study. Surflex-Dock scores (total scores) represent binding affinities.
Cell staining assay
The stage of apoptosis was analyzed using Hoechst 33342 (Beyotime Biotechnology), a dye for livecell fluorescent staining of DNA. Mitochondrial membrane potential was detected using a JC-10 (Beijing Solarbio Science & Technology Co., Ltd., Beijing, China). When the mitochondrial membrane potential is low, JC-10 cannot accumulate in the matrix of the mitochondria, and in the form of a monomer, emits green fluorescence. The procedure followed the manufacturer's protocol instructions. Cells were observed using an inverted fluorescence microscope (OIS IX81, Olympus, Tokyo, Japan) in random microscopic fields. The relative fluorescence intensity was analyzed using ImageJ 1.46r.
Caspase-3 activity detection
The cells were plated in a 6-well plate at a density of 10 6 cells/well. After 24 h, cells were treated with the various drugs for 48 h. Caspase-3 activity was assayed using a Caspase 3 Colorimetric Assay Kit (KeyGen Biotech, Jiangsu, China) following the manufacturer's instructions.
Statistical analysis
Data are generally expressed as the mean ± SD. Significance was evaluated using two-tailed Student's t-tests or one-way analysis of variance using GraphPad Prism 5.01 (GraphPad Software Inc., La Jolla, CA) or SPSS 22.0, respectively. For all tests, a P<0.05 threshold was used to assess significance.
Results

NFV increases the sensitivity of K562/ADR cells to ADR
In order to detect the sensitizing effect of NFV on chemotherapeutic drugs in K562/ ADR cells, a cytotoxicity assay was performed. K562/ADR cells were markedly resistant to ADR, with a resistance index of 63.6. Low concentrations of NFV (≤5 μM) had no influence on the growth of K562/ADR or K562 cell lines ( Fig. 1A, B ; Table 1 ). Therefore, non-toxic concentrations of 1.25, 2.5, and 5 μM NFV were selected to determine the effect on the half maximal inhibitory concentration (IC 50 ) of ADR. NFV was found to reduce the IC 50 of ADR in a dose-dependent manner in K562/ADR cells, and its reversal index reached 10.8 (Fig. 1C , Table 1 ). However, NFV did not affect the sensitivity of the parental cell line to ADR (Fig. 1D ). These data indicated that NFV could reverse the resistance of ADR by K562/ADR cells. 
NFV selectively increases the sensitivity of K562/ADR cells to drugs transported by P-gp
To further clarify the sensitization ability of NFV, four drugs (colchicine, paclitaxel, imatinib, and cisplatin) were used alone or co-administrated with NFV. Notably, NFV enhanced the sensitivity of K562/ADR cells to colchicine, paclitaxel, and imatinib in a dose-dependent manner with the highest reversal indexes of 7.4, 57, and 9.3, respectively, in the K562/ADR cell line. However, NFV did not have a significant influence on sensitization of cisplatin ( Fig.  2 , Table 2 ). These results indicated that NFV was selective for sensitizing chemotherapeutic drugs.
NFV inhibits the P-gp function rather than expression, thus increasing intracellular ADR accumulation
To elucidate the mechanism of NFV reversal of ADR resistance, an ADR intracellular accumulation assay was performed. In K562/ADR cells, NFV increased the fluorescence signal of ADR in a dose-dependent manner. When the NFV concentration reached 5 μM, the intracellular accumulation of ADR was even higher than that of the positive control-verapamil (VRP) group. The ADR fluorescence signal did not change significantly as NFV increased in the K562 cell line (Fig. 3A) . The effect of NFV on P-gp expression, MDR1 level, and efflux function were then assessed using western blot, RT-qPCR, and Rho-123 intracellular accumulation assays, respectively. NFV did not alter the expression of P-gp or the level of MDR1 transcripts, which encode P-gp (Fig. 3B) . NFV increased the intracellular accumulation of Rho-123 in a dose-dependent manner, which suggested the inhibition of the P-gp efflux function. However, in sensitive cell lines, NFV, and VRP did not alter the intracellular accumulation of Rho-123 (Fig. 3C, D) . Taken together, these results suggested that NFV reverses the drug resistance of ADR by inhibiting the efflux function of P-gp and leading to an increase of the intracellular ADR concentration.
ATP is involved in the reversal of MDR by NFV
To further examine the deep mechanism of the reversal effect, we first examined the effects of NFV on mitochondria. The mitochondrial membrane was depolarized by NFV according to the green fluorescence increase observed (Fig. 4D) . The intracellular ATP content was significantly decreased after NFV administration in K562/ADR cells (Fig. 4A) . In order to investigate the effect of ATP content on the reversal ability of NFV, we changed the intracellular ATP content through induction by 1.25, 2.5, and 4.5 g/L glucose (Fig. 4B) . The higher the glucose concentration, the higher the IC 50 value of the ADR, indicating that the NFV reversal ability was weaker (Fig. 4C) . These data suggest that NFVinduced ATP reduction was associated with the ultimate reversal of ADR resistance observed. 
Molecular docking analysis of the binding of NFV with P-gp
To elucidate the interaction between NFV and P-gp, P-gp's X-ray diffraction and electron microscopy structure (PDB ID: 4M2T and 6C0V, respectively) was assessed in a molecular docking simulation. NFV, VRP, ADR, paclitaxel, colchicine, and imatinib had strong affinities with 4M2T, with molecular docking simulation scores of 7.85, 6.91, 6.52, 6.31, 5.2, and 9.61, respectively. However, metformin and cisplatin, which are non-P-gp substrates, showed weak affinities with 4M2T, with binding ability scores of 2.31 and 4.08, respectively [20] . In addition, VRP and ADR had the same amino acid residue binding site for 4M2T, A/GLN986; NFV and ADR also had the same amino acid residue binding site for 4M2T, A/GLN721 (Fig. 5A , Table 3 ). ATP was inferred to form 13 intermolecular hydrogen bonds with 6C0V through 11 amino acid residues at a score of 10.28. NFV and tariquidar, a third-generation P-gp inhibitor, inhibited P-gp indirectly by blocking the activity of ATP synthase, and it had similar affinities with 6C0V, having scores of 9.52 and 9.88, respectively [21] . Moreover, NFV and ATP had the same amino acid residue binding site, A/ARG404; tariquidar and ATP also have the same amino acid residue binding site, A/SER434, which binds to 6C0V (Fig. 5B, Table 3 ). These shared binding sites may competitively inhibit the binding of ATP to P-gp NBD and indirectly inhibit the efflux function of P-gp. A combination of NFV and ADR lead to a significant elevation in intracellular ROS compared to NFV or ADR administered alone (Fig. 6A, B) . In addition, we examined the effect of NFV on the expression of total and phosphorylated Akt and ERK 1/2 in K562/ADR cells. When NFV or ADR was administered alone, the expression of total and phosphorylated Akt and ERK exhibited no alteration. When combined, NFV and ADR administration were associated with significant reductions in phosphorylated Akt and ERK 1/2 expression (Fig. 6C, D) . These results indicated that enhanced cytotoxic responses by co-treatment with NFV and ADR in K562/ADR was associated with an increase of ROS and inhibition of the ERK/Akt pathways. 
Combination of NFV combined with ADR induces apoptosis in K562/ADR cells
To reveal the ultimate mechanism of anti-proliferation induced by NFV combined with ADR, cell apoptosis and the expression and activity of related proteins were measured. First, Hoechst33342 staining indicated nucleus changes. These results showed that the degree of nuclear fragmentation in the drug combination groups was significantly increased, which indicated that cell apoptosis occurred at a higher rate in the drug combination groups relative to the single-drug groups (Fig. 7A) . Second, we detected the proportions of cells exhibiting early cell apoptosis by flow cytometry. In order to avoid fluorescence interference produced by Adriamycin, we used the far-infrared luminescent dye SYTOX Red (635 nm excitation wavelength, 658 nm emission wavelength) and Annexin V for detection.
The result showed that early cell apoptosis was significantly increased in the drug combination groups (Fig. 7B) . In addition, the expression of the Bcl apoptotic protein family and the apoptosis-executing protein caspase-3 were examined by western blot. Compared with the single-drug groups, the expression of cleaved-caspase 3 was significantly increased in the combined NFV and ADR group, and the ratio of anti-apoptotic protein Bcl-2 to proapoptotic protein bax was significantly decreased. The results of the caspase-3 activity assay also confirmed that the drug combination significantly activated caspase-3 to promote apoptosis (Fig. 7C, D, E) . These results indicate that NFV can increase the sensitivity of K562/ ADR to ADR and increase apoptosis of drug-resistant cells to reverse ADR resistance.
Discussion
MDR has hindered the effectiveness chemotherapy of leukemia and other cancers. In contrast with the treatment of solid tumors, leukemia is mainly treated with chemotherapy combined with bone marrow transplantation. The emergence of molecularly targeted drugs is a milestone in CML therapy, which has led to a 10-year overall survival rate of 84% in patients with CML [22, 23] . However, the gradually developed drug resistance associated with CML treatment has attracted the attention of researchers, and one of the causes of drug resistance is P-gp overexpression [4, 24] . K562/ADR cells are a traditional model for studying drug resistance in CML cells. Targeting P-gp to reverse cancer cell resistance is a component of the most widely studied strategies. Four generations of studies on P-gp inhibitors have been performed. However, owing to side effects and low inhibitory ability, there is no drug that can be satisfactorily applied in clinical practice [25] [26] [27] [28] . Our experimental results show that NFV can avoid these two points very well. First, at concentrations of 5 μM and below, NFV did not have significant cytotoxicity, while the reversal index was up to 10.8 (Fig. 1A , Table 1 ), indicating that NFV is a potent reversal agent. Second, one early study showed that single doses (100-800 mg) or multiple doses (800-900 mg) of NFV per day were well tolerated. When NFV was administered orally with food to healthy human volunteers at a dose of 800 mg, the Cmax value was 5.69 ± 1.05 μM [29] . Another phase I clinical trial of NFVtreated solid tumors showed that the drug concentration reached 21 μM and was still well tolerated in subjects at the 2.5 times the FDA-approved dose [30] . Therefore, experimental in vitro data shows that NFV can significantly enhance the sensitivity of drug-resistant cells to ADR, and this concentration of NFV is physiologically easy to achieve. In addition, we also observed that when the concentration of NFV is greater than 5 μM, it demonstrates obvious toxicity to k562 cells (Fig. 1A) . Therefore, whether NFV, a traditional anti-AIDS drug, can be a new type of anti-tumor drug is worthy of further study.
Drug resistance to multiple chemotherapeutic drugs at the same time is one of the main causes of chemotherapy failure [31] . In addition to resistance to ADR, K562/ADR cells also showed different degrees of resistance to colchicine, paclitaxel, imatinib, and cisplatin, which is one of the most prominent features of MDR (Fig. 2, Table 2 ). It is well known that colchicine, paclitaxel, and imatinib are all substrates for P-gp, and cisplatin is neither an inhibitor nor a substrate of P-gp [32] [33] [34] [35] . NFV can selectively reverse the resistance of drugs transported by P-gp; for the non-P-gp substrate drug cisplatin, NFV does not radically change its drug resistance (Fig. 2, Table 2 ). Therefore, we speculate that NFV exerts a reversal effect by targeting P-gp. In addition, the results of cisplatin also suggested that the emergence of drug resistance in K562/ADR cells is a complex issue.
Intracellular accumulation of ADR showed that NFV increased the content of intracellular ADR in a dose-dependent manner (Fig. 3A) . These experiments demonstrate that NFV reverses resistance by increasing the content of intracellular drugs. ADR is a substrate of P-gp, and P-gp is overexpressed in K562/ADR cells, so we speculate that NFV inhibits P-gp and leads to an increase in intracellular drugs [36] . Therefore, we examined the interaction between NFV and P-gp through both the function and expression of P-gp. First, we found that P-gp expression and its gene transcript levels were not down-regulated after K562/ ADR cells were administered NFV for 48 h. Functionally, NFV inhibited the efflux of the P-gpspecific fluorogenic substrate Rho-123 in a dose-dependent manner, which indicates NFV inhibited P-gp efflux function (Fig. 3B, C, D) .
P-gp transports one molecule of the substrate across the membrane, requiring two molecules of ATP to provide energy [37] . If the energy supply is insufficient, the function of P-gp is inhibited [38, 39] . The mitochondrion is the "powerhouse" of eukaryotic cells and the principal organelle involved in the production of ATP. Our study found that NFV can reduce mitochondrial membrane potential (Fig. 4D ). This phenomenon is also called mitochondrial permeability transition (MPT), in which some low molecular weight solutes (<1.5 kDa) are infiltrated into the mitochondrial matrix, affecting its structure and leading to mitochondrial function collapse [40] . For the "powerhouse" of the cell, this will inevitably affect the intracellular ATP content, which is consistent with our experimental results (Fig.  4A) . When the intracellular ATP content increases, the reversal ability of NFV is weakened, which also indirectly indicates that the decrease in ATP content caused by NFV is one of the reasons for the observed reversal of drug resistance (Fig. 4B, C) .
The basic structure of P-gp contains four core active regions, namely two hydrophilic nucleotide-binding domains (NBD) located in the cytoplasm that are responsible for binding to ATP and two hydrophobic transmembrane domains (TMD) that are responsible for binding to the substrate for P-gp transport [37, 41] . For 4M2T, a corrected structure of mouse P-gp bound to QZ59-SSS, the corrected position of TMD4, which forms the frame of a portal for drug entry. The drug translocation pathway of Mouse P-gp is 96% identical to human P-gp and is enriched for aromatic residues that likely play a collective role in allowing a high degree of poly-specific substrate recognition [42] . Therefore, we chose 4M2T as a protein stereo structure model for binding drugs to TMD. For 6C0V, a new molecular structure of human P-gp was inferred to have an ATP-bound, outward-facing conformation. The researchers further found that the binding of ATP and NBD sites promoted drug release rather than hydrolysis [43] . Therefore, we chose 6C0V as a protein stereo structure model for binding drugs to NBD. Results of molecular docking simulation explain the interaction of NFV with P-gp active functional regions. NFV has a strong binding ability to TMD and NBD, and it has a common binding site with ADR and ATP in the corresponding functional regions. These common binding sites may result in inhibition of the binding of P-gp to drugs or ATP, resulting in the efflux function of P-gp being affected (Fig. 5) . In addition, we also found that VRP and ADR have the same binding site. Similarly, Tariquidar and ATP also have the same binding site, but these binding sites differ from those of NFV. If these particular amino acid residues can be mutated, the binding of P-gp to the drug is blocked, and the normal physiological function of P-gp is not affected, which may eventually solve the drug resistance problem caused by P-gp.
ROS, as signaling molecules, participate in tumor cell proliferation inhibition, autophagy, apoptosis, and drug resistance. ROS inhibit cell proliferation mainly through mitogenassociated protein kinases (MAPKs) [44] . MAPKs comprise a highly conserved family of serine/threonine protein kinases that plays a role in many essential cellular processes. The MAPK family includes extracellular signal-regulated kinases 1 and 2 (ERK1/2), JNK, Erk5, and others [45] . Protein Kinase B, also known as Akt, regulates multiple biological processes, including cell survival, proliferation, growth, and glycogen metabolism [46] . The activation of the PI3K/Akt and MAPK/ERK pathway is related to the development of MDR in cancer cells [47] [48] [49] . Cancer cells are not sensitive to chemotherapeutic drugs, leading to a reduction in cell death caused by chemotherapeutic drugs, which leads to the emergence of drug resistance. After the development of drug resistance in cells, changes in the proteins that are related to the drug-induced survival signal pathway are not obvious.
The results showed that 2 μM ADR alone did not significantly change the expression of total or phosphorylated ERK/Akt and intracellular ROS generation. When ADR was combined with NFV, the survival pathway was blocked, and ADR-induced apoptosis was significantly increased. Hoechst33342 staining, AV/SYTOX double staining, caspase-3activity detection, and Bcl-2/bax protein expression assays confirmed this trend (Fig. 6, Fig. 7 ).
Conclusion
As an "off-the-shelf" drug, NFV is effective in reversing K562/ADR cell resistance below physiologically acceptable concentrations. NFV can inhibit the function of P-gp by inducing intracellular ATP content and competitive drugs with ATP and P-gp binding sites, thereby increasing intracellular accumulation of ADR and exerting a reversal effect. The combination of NFV and ADR leads to an increase of ROS, blocking the ERK/Akt signaling pathway to increase apoptosis.
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